These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11881747)

  • 21. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Applications of antisense-RNA technology in filamentous fungal metabolic engineering--a review].
    Ding Y; Li S; Huang H
    Sheng Wu Gong Cheng Xue Bao; 2009 Sep; 25(9):1316-20. PubMed ID: 19938473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In search of antisense.
    Lavorgna G; Dahary D; Lehner B; Sorek R; Sanderson CM; Casari G
    Trends Biochem Sci; 2004 Feb; 29(2):88-94. PubMed ID: 15102435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. William Pardridge discusses the lack of BBB research. Interview by Rebecca N. Lawrence.
    Pardridge WM
    Drug Discov Today; 2002 Feb; 7(4):223-6. PubMed ID: 11839516
    [No Abstract]   [Full Text] [Related]  

  • 25. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antisense gene therapy of respiratory syncytial virus infection].
    Cui YX; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):629-32. PubMed ID: 17083798
    [No Abstract]   [Full Text] [Related]  

  • 27. [Establishment of urokinase receptor gene antisense RNA transfer system and its application in leukemia research].
    Bai X; Fu JX; Xi XD; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):591-4. PubMed ID: 14706141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibition of beta-globin RNA transcripts by antisense RNA molecules.
    Pace BS; Qian X; Ofori-Acquah SF
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):43-51. PubMed ID: 15040426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted inhibition of hepatitis B virus gene expression: a gene therapy approach.
    Tung FY; Bowen SW
    Front Biosci; 1998 Feb; 3():a11-5. PubMed ID: 9450988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antisense RNA therapy for CML--an hypothesis.
    Nadkarni KS; Datar RH; Rao SG
    Med Hypotheses; 1991 Aug; 35(4):307-10. PubMed ID: 1943880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives of choroidal neovascularization therapy.
    Caputo M; Zirpoli H; Di Benedetto R; De Nadai K; Tecce MF
    Curr Drug Targets; 2011 Feb; 12(2):234-42. PubMed ID: 20887238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense catalytic RNAs as therapeutic agents.
    Castanotto D; Rossi JJ; Sarver N
    Adv Pharmacol; 1994; 25():289-317. PubMed ID: 8204504
    [No Abstract]   [Full Text] [Related]  

  • 33. Antisense technology for cancer therapy: does it make sense?
    Carter G; Lemoine NR
    Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitochondrial delivery of antisense RNA by MITO-Porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria.
    Furukawa R; Yamada Y; Kawamura E; Harashima H
    Biomaterials; 2015 Jul; 57():107-15. PubMed ID: 25913255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of antimicrobial targets using a comprehensive genomic approach.
    Yin D; Fox B; Lonetto ML; Etherton MR; Payne DJ; Holmes DJ; Rosenberg M; Ji Y
    Pharmacogenomics; 2004 Jan; 5(1):101-13. PubMed ID: 14683422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Introduction: gene therapy has gone from a pipe dream to clinical reality.
    Kordower JH; Kirik D
    Neurobiol Dis; 2012 Nov; 48(2):151-2. PubMed ID: 22841531
    [No Abstract]   [Full Text] [Related]  

  • 37. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic engineering within the adult brain: implications for molecular approaches to behavioral neuroscience.
    Lowenstein PR; Castro MG
    Physiol Behav; 2001 Aug; 73(5):833-9. PubMed ID: 11566216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense RNA sequences modulating the ataxin-1 message: molecular model of gene therapy for spinocerebellar ataxia type 1, a dominant-acting unstable trinucleotide repeat disease.
    Gao Y; Zu T; Low WC; Orr HT; McIvor RS
    Cell Transplant; 2008; 17(7):723-34. PubMed ID: 19044200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA as a target for developing antivirals.
    McKnight KL; Heinz BA
    Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.